Advisory fee shares
Company: Core Scientific
The claim, verbatim
Core Scientific issued 386,697 shares of Common Stock to B. Riley Securities, Inc. as an advisory fee in connection with execution of two amended and restated bridge promissory notes on August 1, 2022
Source (primary)
Core Scientific 424B3 filed 2022-10-27 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “shares of Common Stock that we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022, one with B. Riley Commercial Capital, LLC and one with an affiliate of B. Riley Commercial Capital, LLC”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document states the 386,697 Advisory Fee Shares to BRS tied to the August 1, 2022 bridge notes.
Confirmed in the source:
- Core Scientific issued 386,697 shares to B. Riley Securities, Inc. as an advisory fee
- The advisory fee related to execution of two amended and restated bridge promissory notes on August 1, 2022
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522270429/d395956d424b3.htm) in full (18,255 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-27
Quote: “shares of Common Stock that we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022, one with B. Riley Commercial Capital, LLC and one with an affiliate of B. Riley Commercial Capital, LLC”